China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year

Aug.22
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.

On the evening of August 22, Beijing time, China Tobacco International (Hong Kong) Company Limited (6055.HK) released its interim results for the period ended June 30, 2025.

Key Data:

 

  • Revenue: HKD 10.32 billion, up 18.5% year-on-year
  • Gross profit: HKD 946 million, down 1.8% year-on-year
  • Net profit attributable to shareholders: HKD 706 million, up 9.8% year-on-year
  • Earnings per share: HKD 1.02 (2024 H1: HKD 0.93)
  • Interim dividend: HKD 0.19 per share, up 26.7% year-on-year

 

Performance by Business Segment

 

  • Tobacco leaf import business: Revenue HKD 8.399 billion, up 23.5% year-on-year; however, gross profit margin declined, gross profit decreased by 7.7%.
  • Tobacco leaf export business: Revenue HKD 1.156 billion, up 25.9% year-on-year; gross profit increased by 124.1%, becoming the main driver of profit growth.
  • Cigarette export business: Sales volume decreased by 7.9%, but with structural optimization and expansion of self-operated channels, revenue remained basically flat (+0.8%), and gross profit increased by 16.8%.
  • New tobacco export business: Affected by geopolitical and regulatory factors, revenue was HKD 14.6 million, down 66.5% year-on-year.
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (HK) Mid-term Financial Report screenshot for 2025 | Source: China Tobacco International (HK) Financial Report

 

Finance and Outlook

 

  • Financing cost: Down 28.2% to HKD 82.9 million, easing profit pressure.
  • Cash and deposits: HKD 3.98 billion, significantly increased compared with the end of 2024.
  • Outlook for the second half: The company emphasized that it will continue to strengthen the resilience of the tobacco leaf supply chain, expand duty-free cigarette channels, and promote innovation and market access for new tobacco products, in order to cope with international regulatory and geopolitical risks.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore's four-day joint operation to investigate e-cigarettes resulted in the arrest of four e-cigarette users
Singapore's four-day joint operation to investigate e-cigarettes resulted in the arrest of four e-cigarette users
Singapore's HSA & NEA held a 4-day joint op against e-cig use in Tampines, CBD & other areas: 4 offenders (24-43) caught, fined on-site; 27 e-cigs/accessories seized. Singapore also tightened e-cig enforcement, authorizing over 5k frontline officers on Sept 9; stricter penalties took effect Sept 1—1st under-18s: S$500 (≈US$389), 18+: S$700 (≈US$545); 2nd offenders: 3-mth rehab; 3rd+: prosecution, up to S$2k (≈US$1,557). Etomidate e-cig users face harsher penalties (higher fines, rehab) & prosecu
Sep.22 by 2FIRSTS.ai
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
This article is based on research materials provided by an Argentine team and edited by 2Firsts. It reviews the latest developments in South America’s NGP market, covering regulatory differences, environmental challenges, and the balance between harm reduction and sustainability.
Aug.25
Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million
Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million
The WHO Western Pacific Regional Director recently presented the WHO Global Award to Vietnamese Minister of Health Đào Hồng Lan. The tax reforms in the newly revised 2025 Special Consumption Tax Law will enable 2.1 million people in Vietnam to quit or not start smoking by 2031, and will also generate an additional VND24 trillion (US$910 million) in annual state revenue.
Sep.28
UK busts major illegal e-cigarette case involving 120,000 units; ringleader gets one year in prison
UK busts major illegal e-cigarette case involving 120,000 units; ringleader gets one year in prison
In 2024, UK trading standards uncovered a nationwide illegal e-cigarette supply operation. Business owner Amandeep Kukraja supplied nearly 120,000 illegal products nationwide and received a 12-month probation sentence plus forfeiture of over £300,000 in criminal proceeds.
Sep.12 by 2FIRSTS.ai
EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision
EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision
EU to assess health impact of e-cigarettes and nicotine-containing products for the first time during tobacco directive revision.
Sep.22 by 2FIRSTS.ai